Additional European Equity News
AstraZeneca (AZN LN) - The CALLA Phase III trial for AstraZeneca’s Imfinzi given concurrently with chemoradiotherapy (CRT) did not achieve statistical significance for the primary endpoint of improving progression-free survival (PFS) versus CRT alone in the treatment of patients with locally advanced cervical cancer. (AstraZeneca)
Krones (KRN GY) - Final FY21 (EUR): Revenue 3.63bln (prelim 3.63bln). EBITDA 312.6mln (prelim. 312.6mln). EBITDA margin +8-9%. (Newswires)
Next (NXT LN) - FY21 (GBP): pre-tax 823mln (exp. 822.5mln). Co. cuts profit guidance amid the Russia-Ukraine war. Co. is to restart dividend payment and says in the year ahead, it will return to pre-pandemic dividend cycle. EPS +12% Y/Y. (Newswires)
Scout24 (G24 GY) - FY21 (EUR): Revenue 389mln (prev. 353.8mln Y/Y)). EBITDA 222.8mln (prev. 212.3mln); proposes dividend in the upper range of policy. (Newswires)
Tullow Oil (TLW LN) - Appoints Jonathan Swinney as CFO. (Newswires)
Nokian (TYRES FH) downgraded to Hold from Buy at Nordea
24 Mar 2022 - 07:40- Research Sheet- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts